相关实验视频
Updated: Jul 11, 2025

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
7.7K
在心力衰竭中治疗睡眠呼吸暂停的新方法
Gregory R Jackson1, Abhinav Singh2
1Medical University of South Carolina, Ralph H. Johnson Veterans Affairs Medical Center, Thurmond Gazes Building, 30 Courtenay Drive, BM206, MSC592, Charleston, SC 29425, USA.
Heart failure clinics
|November 12, 2023
概括
睡眠呼吸暂停,常见于心力衰竭患者,增加心血管风险. 创新的家庭疗法为治疗这种疾病和改善患者治疗结果提供了新的希望.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 睡眠医学 睡眠医学
背景情况:
- 睡眠呼吸暂停影响50-75%的心力衰竭患者.
- 它经常被诊断不足和治疗不足.
- 同时存在的睡眠呼吸暂停和心力衰竭会增加不良心血管事件和突然死亡的风险.
研究的目的:
- 对心力衰竭患者睡眠呼吸暂停的新兴家庭技术和设备疗法进行审查.
- 探索这种并发性疾病的新型治疗策略.
主要方法:
- 关于睡眠呼吸暂停和心力衰竭的当前文献的综述.
- 分析不断发展的家庭技术和设备疗法.
- 根据睡眠呼吸暂停类型和干预措施评估治疗结果.
主要成果:
- 在心力衰竭中治疗睡眠呼吸暂停的疗效显示出不同的结果.
- 基于家庭的技术和设备疗法是一个有前途的干预领域.
- 需要进一步的研究来优化治疗策略.
结论:
- 睡眠呼吸暂停是严重的,经常被忽视的,心力衰竭的并发症.
- 基于家庭的创新方法有可能改善结果.
- 个性化治疗策略对于控制心力衰竭中的睡眠呼吸暂停至关重要.
相关概念视频
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Sleep Apnea
161
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
161
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Heart Failure VII: Nursing Interventions
85
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
85
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14

